While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease remains a leading killer of women in low- and middle-income countries for lack of access to screening and trained providers.
Kathleen Schmeler, M.D., professor of Gynecologic Oncology and Reproductive Medicine, is working change this. Her work to prevent and treat cervical cancer has taken...
November is Lung Cancer Awareness Month, and the third Thursday of each November is designated by the American Cancer Society as the Great...
The recent outbreak of lung injury and death associated with e-cigarettes and vaping has led to a renewed scrutiny of electronic nicotine...
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine to protect against multiple types of cancer, several recent studies show that public knowledge about the vaccine and HPV’s relationship to cancer remains low.
HPV is responsible for 90% of cervical and anal cancers, and 70% of oropharyngeal (throat) cancers.
The first-generation HPV...
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million...
Increasing the dosage of a prescription smoking cessation medication by 1 milligram a day – from 2 to 3 milligrams – more than doubled abstinence...
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the University...
Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as...